Tetragenetics

United States
Boscawen, New Hampshire, United States, 14850

Company profile

Tetragenetics company profile

Tetragenetics is an early-stage biotechnology company meeting the needs of customers who seek a cost-effective alternative platform technology for the production of genetically engineered proteins. Their technology is particularly well suited to the production of eucaryotic membrane and secretory proteins that are difficult to express in conventional systems. Such proteins include vaccine antigens, monoclonal antibodies, and a variety of therapeutic proteins for the treatment and prevention of human and animal disease.

Business identity

Contact email
[email protected]
Phone number
6174013754
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2004-01-01, Year

Headquarters

Postal code
14850
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
14
Total equity funding
$4.6M
Last funding
Debt Financing / $1M / 2020-09-29
Last equity funding
Series Unknown / $809,770
Investors
8
Lead investors
2
Founders
1
Articles
3
Exited on
2021-09-13

Founders and investors

Founders

Bill Gordon

Lead investors

Bill & Melinda Gates FoundationExcell Partners

Investors

Bill & Melinda Gates FoundationExcell PartnersJDRF T1D FundLaunchPad VentureNational Institutes of Health